#CART25
Planes sir! The sky has no limits! #EBMT #CART25
February 8, 2025 at 10:42 AM
Really fantastic session on the importance of shared decision making rounding off a brilliant nursing and AHP programme at EHA EBMT #CART25
February 7, 2025 at 5:57 PM
MAKE CAR-T AFFORDABLE AGAIN

Terrific learning experience from cellular therapy programs in India, Slovenia, Brazil and Turkey

#CART25
February 8, 2025 at 2:58 PM
Judith presented our recent #CARTcell research at the 7th European CAR T cell Meeting #CART25 in Strasbourg.🧬🧫
Many thanks to the organizers @EHA_Hematology and @EBMT for this inspiring event.
#TeamJJ
February 12, 2025 at 10:15 AM
Christian Chabannon presenting on the progress of #GoCARTcoalition a European initiative aiming to increase access to this exciting new therapies to cancer patients and patients with auto immune diseases. #EBMT #EHA #CART25
February 7, 2025 at 7:41 AM
What a great pre meeting before #CART25 in Strassbourg of #T2Evolve and #GoCART coalition on developing consensus on collected CART data as well as registry interactions using OMOPing
February 6, 2025 at 10:24 AM
At the European CAR T-cell meeting, we spoke with Johanna Richter to hear about the preliminary data from a single-center experience with CD19-directed CAR-T in patients with #MultipleSclerosis.

Watch here:
👉 buff.ly/Xyuvgwu

#MS #MultScler #CART25 #Neurology
March 21, 2025 at 11:16 AM
🩸To hear the results of a Phase II study of parsaclisib for the treatment of primary autoimmune hemolytic #anemia, watch our recent interview with Prof. Ulrich Jäger below:

🎥 buff.ly/XXAXe4j

#CART25 #Hematology #CTSM #TrialUpdate #MedSky #BloodSky
March 18, 2025 at 2:00 PM
Are in vivo genome editing methods for targeting T-cells the future of CAR-T?🧬

What are some of their benefits, and what challenges remain?

Hear from Dr William Nyberg in a recent interview from #CART25:

🎥 buff.ly/E146kjE

#ImmunoOnc #HemOnc #CARTCell #BloodSky
March 15, 2025 at 1:00 PM
In an interview from #CART25, Prof. Christian Buchholz shares insight into advancements in #CARTCell manufacturing, mentioning two novel strategies being developed – short-term CAR T-cells & in vivo CAR delivery.

Watch here:
👉 buff.ly/49Y0DOh

#ImmunoOnc #HemOnc
March 13, 2025 at 2:00 PM
At #CART25 we had the pleasure of speaking with the lovely @orlamccourt.bsky.social of @uclh.bsky.social to gain insight into a single-center experience of implementing physiotherapist-led prehabilitation for #CARTCell therapy.

Click here to learn more:
👉 buff.ly/8UM5VqR

#ImmunoOnc #HemOnc
A single-center experience of implementing physiotherapist-led prehabilitation for CAR-T therapy
In this video, Orla McCourt, MSc, MCSP, University College London NHS Foundation Trust, London, UK, presents a single-center experience implementing...
ow.ly
March 12, 2025 at 11:54 AM
Could mitochondrial transfer be harnessed to improve the efficacy of T-cell therapy?

Luca Gattinoni is studying this, and we had the pleasure of hearing about his work at the recent European CAR-T Meeting!

Watch here:
👉 buff.ly/bFko3tk 👈

#ImmunoOnc #HemOnc #CART25
March 11, 2025 at 12:00 PM
At #CART25, the lovely Natacha Bolaños shared an analysis of the Lymphoma Coalition’s Global Patient Survey investigating patient-reported side effects for #CARTCell therapy vs other therapies in relapsed lymphomas & CLL.

Click to watch:

🎥 buff.ly/zDEwxYQ

#LYMsm #Leusm #CLLsm #HemOnc
March 9, 2025 at 3:00 PM
At #CART25, Maik Luu spoke on the potential of microbiome-derived metabolites to guide patient outcome prediction & #CARTCell engineering, highlighting the discovery of the microbial postbiotic pentanoate:

🎥 buff.ly/F32c2Ra

#ImmunoOnc #HemOnc
March 7, 2025 at 1:00 PM
🎥 In an interesting interview at #CART25, Andrea Kuhnl provided insight into CAR-T outcomes in patients with LBCL in the UK according to ethnicity and socioeconomic deprivation.

Watch here:
👉 buff.ly/3KHC04h 👈

#LYMsm #DLBCL #ImmunoOnc #HemOnc
March 6, 2025 at 11:00 AM
Did you miss this year's EHA-EBMT European CAR T-cell meeting?🩸💉

Not to worry! We were there to capture key updates.🎥

You can check out our exclusive expert interviews from the event here:
👉 buff.ly/RID6wue 👈

#ImmunoOnc #CARTCell #CART25
March 5, 2025 at 11:05 AM
#CART25 | Christian Chabannon shares updates on ongoing projects of the #GoCARTcoalition!

Click here to watch the interview:
👉 buff.ly/4hSG1Po 👈

#ImmunoOnc #HemOnc #CARTCell #Hematology #MedSky #BloodSky #HemeSky
February 25, 2025 at 1:46 PM
The incidence of cardiac complications after CAR T-cell therapy may be higher than initially thought.🫀💉

Watch our interview with Roni Shouval of @mskcancercenter.bsky.social from #CART25 to find out more:

👉 buff.ly/415vNnB 👈

#ImmunoOnc #HemOnc #CARTCell #Hematology #MedSky #BloodSky #HemeSky
The incidence of cardiac complications after CAR T-cell therapy
Roni Shouval, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, comments on the incidence of cardiac complications after...
buff.ly
February 21, 2025 at 11:11 AM
Hear about the status of #CARTCell therapy in acute and chronic leukemias (ALL, AML, CLL) in our interview from #CART25 with Ulrich Jäger:

👉 https://buff.ly/3QhuKfw 👈

#Leusm #Leukemia #ALLsm #AMLsm #CLLsm #ImmunoOnc #HemOnc
February 20, 2025 at 11:00 AM
Thank you to Valentín Ortiz-Maldonado for stopping by at #CART25 to share the results of the pivotal CART19-BE-02 trial investigating var-cel in adult R/R B-ALL!

Watch here:
👉 https://buff.ly/3EDdDCs

#ALLsm #Leusm #CARTCell #CTSM #TrialUpdate #ImmunoOnc #MedSky #BloodSky #HemeSky #HemeOnc
February 18, 2025 at 4:49 PM
🎥 Check out our recent interview from #CART25 with @nicogagelmann.bsky.social, in which he highlights the need to address inequality & inequity in access to #CARTCell therapy across Europe:

👉 buff.ly/4gBhWeD

#ImmunoOnc #HemOnc #Hematology #MedSky #BloodSky #HemeSky
February 18, 2025 at 3:54 PM
At #CART25, we had the pleasure of speaking with Elise Pennings & Anne Spanjaart, who shared insight into their work on patient-reported outcomes of #CARTCell therapy.

Don't miss this fantastic interview:
👉 https://buff.ly/41dvdpp 👈

#HemOnc #Hematology #MedSky #BloodSky #HemeSky #LYMsm
February 17, 2025 at 9:00 AM
#CART25 | Tanya Siddiqi of @cityofhope.bsky.social shares updates on the recent approval of CAR-T for patients with CLL, commenting on where #CARTCell therapy may fit into the treatment landscape and referencing the TRANSCEND-CLL-004 trial:

🎥 https://buff.ly/3CR8E0f

#CLLsm #Leusm #CTSM #HemOnc
February 14, 2025 at 2:00 PM
At #CART25 last week, Pere Barba of @vhio.bsky.social shared updated results from the FELIX trial, evaluating obe-cel in patients with R/R ALL.

Watch the interview here:
👉 https://buff.ly/40SDhKF 👈

#ALLsm #Leusm #CTSM #TrialUpdate #ImmunoOnc #MedSky #BloodSky #HemeSky #HemeOnc
February 13, 2025 at 5:04 PM
We had a fantastic time at the 7th European CAR T-cell meeting!💉🩸

Thank you to the EBMT & EHA for having us onsite as a media partner again this year!😁

Check out some of our exclusive coverage of the event here:
👉 https://buff.ly/3QeT6qd 👈

#CART25 #CARTCell #Hematology #MedSky #BloodSky #HemeSky
February 13, 2025 at 1:01 PM